focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 39.00
Ask: 40.00
Change: -1.50 (-3.66%)
Spread: 1.00 (2.564%)
Open: 41.00
High: 41.00
Low: 39.50
Prev. Close: 41.00
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [ CENTAUR MEDIA PLC - Opening Disclosure - 10 04 2024] - (CGAML)

11 Apr 2024 11:08

Form 8.3 - [ CENTAUR MEDIA PLC - Opening Disclosure - 10 04 2024] - (CGAML)

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCENTAUR MEDIA PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure10 APRIL 2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:10p ORDINARY
 InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:2,000,0001.3618  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:2,000,0001.3618  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
NONE   

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
NONE   

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:11 APRIL 2024
Contact name:MARK ELLIOTT
Telephone number:01253 376539

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
24th Sep 20199:55 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSAppointment of Joint Broker
4th Sep 20197:00 amRNSSwag Mukerji succeeds Andria Vidler as CEO
30th Aug 20197:00 amRNSTotal Voting Rights
22nd Aug 201912:00 pmRNSReplacement - Holding(s) in Company
21st Aug 201911:45 amRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSTotal Voting Rights
22nd Jul 20194:12 pmRNSDirector/PDMR Shareholding
11th Jul 20197:00 amRNSCentaur completes divestment programme
1st Jul 20197:00 amRNSColin Jones succeeds Neil Johnson as chairman
28th Jun 20197:00 amRNSTotal Voting Rights
20th Jun 20192:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20197:00 amRNSCentaur completes disposal
31st May 20197:00 amRNSTotal Voting Rights
23rd May 201910:46 amRNSDirector/PDMR Shareholding
17th May 20193:21 pmRNSResult of AGM
17th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSCentaur agrees sale of engineering portfolio
1st May 201911:50 amRNSCentaur completes disposal of CTM
1st May 20197:00 amRNSCentaur completes disposal of HR business
30th Apr 20197:00 amRNSTotal Voting Rights
24th Apr 201911:09 amRNSDirector/PDMR Shareholding
18th Apr 20191:13 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSCentaur agrees sale of HR business
10th Apr 20197:00 amRNSCentaur agrees sale of CTM to Northstar
3rd Apr 201911:00 amRNSAnnual Financial Report
1st Apr 20197:00 amRNSCentaur sells financial services to Metropolis
29th Mar 20197:00 amRNSTotal Voting Rights
21st Mar 201910:06 amRNSDirector Declaration
20th Mar 201912:01 pmRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSResults for the year ended 31 December 2018
28th Feb 20197:00 amRNSTotal Voting Rights
21st Feb 201910:26 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSTotal Voting Rights
22nd Jan 201911:33 amRNSDirector/PDMR Shareholding
22nd Jan 20197:00 amRNSCentaur's marketing division rebrands as XEIM
22nd Jan 20197:00 amRNSYear end trading update
2nd Jan 20197:00 amRNSTotal Voting Rights
19th Dec 20183:16 pmRNSDirector/PDMR Shareholding
30th Nov 20187:00 amRNSExtension of Existing Banking Facility
30th Nov 20187:00 amRNSTotal Voting Rights
20th Nov 20183:12 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSAppointment of advisers to assist with divestment
15th Nov 20184:40 pmRNSSecond Price Monitoring Extn
15th Nov 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20187:00 amRNSTotal Voting Rights
25th Oct 20187:00 amRNSTrading Statement
25th Oct 20187:00 amRNSTrading update and accelerated simplification plan
24th Oct 20183:56 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.